Author/Creator: Ehrenforth, S. - British Library Electronic Legal Deposit Catalogue-Journal Issues and Articles Search Results

Author/Creator Ehrenforth, S.

1. Changes in the amino acid sequence of the recombinant human factor VIIa analog, vatreptacog alfa, are associated with clinical immunogenicity. (13th October 2015)

Authors:: Mahlangu, J. N.; Weldingh, K. N.; Lentz, S. R.; Kaicker, S.; Karim, F. A.; Matsushita, T.; Recht, M.; Tomczak, W.; Windyga, J.; Ehrenforth, S.; Knobe, K.
Journal:: Journal of thrombosis and haemostasis
Issue:: Volume 13:Number 11(2015:Nov.)
Page Start:: 1989
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

2. First report on the safety and efficacy of an extended half‐life glycoPEGylated recombinant FVIII for major surgery in severe haemophilia A. Issue 5 (4th May 2017)

Authors:: Hampton, K.; Chowdary, P.; Dunkley, S.; Ehrenforth, S.; Jacobsen, L.; Neff, A.; Santagostino, E.; Sathar, J.; Takedani, H.; Takemoto, C. M.; Négrier, C.
Journal:: Haemophilia
Issue:: Volume 23:Issue 5(2017)
Page Start:: 689
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗

3. Recombinant factor VIIa analog in the management of hemophilia with inhibitors: results from a multicenter, randomized, controlled trial of vatreptacog alfa. (16th July 2014)

Authors:: Lentz, S. R.; Ehrenforth, S.; Abdul Karim, F.; Matsushita, T.; Weldingh, K. N.; Windyga, J.; Mahlangu, J. N.; the adept™2 investigators
Journal:: Journal of thrombosis and haemostasis
Issue:: Volume 12:Number 8(2014:Aug.)
Page Start:: 1244
Record Type:: Journal Article
View Content:: Available online (eLD content is only available in our Reading Rooms) ↗